RxDoctor Payments Data

Quinn Charbonneau, DPM

Podiatrist · Winthrop, MANPI 1144541327

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $649 and has fallen 96.0% since, to $26 in 2025.

$1,505in general payments, 2019–2025

Across 27 payments — averaging $55.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$354
  • Mimedx Group, Inc.$270
  • Smith+Nephew$225
  • Paratek Pharmaceuticals, Inc.$171
  • Kerecis Limited$135
  • Trilliant Surgical LLC.$124
  • plus $226 from 7 others

What the payments were for

  • Travel & lodging$141%
  • Food & beverage$1,49099%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,505 in reported general payments places this provider in the 70th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$455,522
Medicare patients
1,616
Services billed
8,951

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole20$347
Mupirocin12$111

Paid to pharmacies, not to this prescriber.

Other podiatrist in Winthrop

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →